New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...

The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

Explore updates on potential GLP-1 uses and risks, including addiction treatment, bone injury concerns, and kidney disease effectiveness.

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

Osteoporosis is a silent condition that affects 10 million Americans, and 44 million have low bone density, yet 80% of older Americans who suffer bone breaks are not tested or treated for osteoporosis ...

A bone-crushing side effect? The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...

Experts have told women for a long time that certain medical conditions and habits, including poor diet, lack of exercise and smoking, make osteoporosis more likely. Now research has added another ...